Romeo A. Mandanas

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 543 citations · Full text

Cobimetinib Versus Regorafenib, Oncology, Medicine +10

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.

J. Beyer, A. Kramar, Romeo A. Mandanas et al. · Journal of Clinical Oncology · 1996 · 319 citations

Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care

David J. Kuter, Susan D. Mathias, Mathias Rummel et al. · American Journal of Hematology · 2012 · 77 citations

Quality Of Life, Immunology, Pharmacotherapy +17

Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors

María Cecilia Foncuberta, P. J. Cagnoni, Christian Brandts et al. · Journal of Immunotherapy · 2001 · 52 citations

Bullous esophagitis due to chronic graft-versus-host disease.

A Minocha, Romeo A. Mandanas, M Kida et al. · PubMed · 1997 · 34 citations

Chronic Gvhd, Transplantation, Bullous Esophagitis +9